BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 20031603)

  • 1. A genome-wide association scan of RR and QT interval duration in 3 European genetically isolated populations: the EUROSPAN project.
    Marroni F; Pfeufer A; Aulchenko YS; Franklin CS; Isaacs A; Pichler I; Wild SH; Oostra BA; Wright AF; Campbell H; Witteman JC; Kääb S; Hicks AA; Gyllensten U; Rudan I; Meitinger T; Pattaro C; van Duijn CM; Wilson JF; Pramstaller PP;
    Circ Cardiovasc Genet; 2009 Aug; 2(4):322-8. PubMed ID: 20031603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple independent genetic factors at NOS1AP modulate the QT interval in a multi-ethnic population.
    Arking DE; Khera A; Xing C; Kao WH; Post W; Boerwinkle E; Chakravarti A
    PLoS One; 2009; 4(1):e4333. PubMed ID: 19180230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration.
    Eijgelsheim M; Aarnoudse AL; Rivadeneira F; Kors JA; Witteman JC; Hofman A; van Duijn CM; Uitterlinden AG; Stricker BH
    Hum Mol Genet; 2009 Jan; 18(2):347-57. PubMed ID: 18927126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study.
    Lehtinen AB; Newton-Cheh C; Ziegler JT; Langefeld CD; Freedman BI; Daniel KR; Herrington DM; Bowden DW
    Diabetes; 2008 Apr; 57(4):1108-14. PubMed ID: 18235038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.
    Kao WH; Arking DE; Post W; Rea TD; Sotoodehnia N; Prineas RJ; Bishe B; Doan BQ; Boerwinkle E; Psaty BM; Tomaselli GF; Coresh J; Siscovick DS; Marbán E; Spooner PM; Burke GL; Chakravarti A
    Circulation; 2009 Feb; 119(7):940-51. PubMed ID: 19204306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between NOS1AP single nucleotide polymorphisms (SNPs) and QT interval duration in four racial/ethnic groups in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Shah SA; Herrington DM; Howard TD; Divers J; Arnett DK; Burke GL; Kao WH; Guo X; Siscovick DS; Chakravarti A; Lima JA; Psaty BM; Tomaselli GF; Rich SS; Bowden DW; Post W
    Ann Noninvasive Electrocardiol; 2013 Jan; 18(1):29-40. PubMed ID: 23347024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.
    Aarnoudse AJ; Newton-Cheh C; de Bakker PI; Straus SM; Kors JA; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
    Circulation; 2007 Jul; 116(1):10-6. PubMed ID: 17576865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ancestry and common genetic variants on QT interval in African Americans.
    Smith JG; Avery CL; Evans DS; Nalls MA; Meng YA; Smith EN; Palmer C; Tanaka T; Mehra R; Butler AM; Young T; Buxbaum SG; Kerr KF; Berenson GS; Schnabel RB; Li G; Ellinor PT; Magnani JW; Chen W; Bis JC; Curb JD; Hsueh WC; Rotter JI; Liu Y; Newman AB; Limacher MC; North KE; Reiner AP; Quibrera PM; Schork NJ; Singleton AB; Psaty BM; Soliman EZ; Solomon AJ; Srinivasan SR; Alonso A; Wallace R; Redline S; Zhang ZM; Post WS; Zonderman AB; Taylor HA; Murray SS; Ferrucci L; Arking DE; Evans MK; Fox ER; Sotoodehnia N; Heckbert SR; Whitsel EA; Newton-Cheh C;
    Circ Cardiovasc Genet; 2012 Dec; 5(6):647-55. PubMed ID: 23166209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval.
    Kapoor A; Sekar RB; Hansen NF; Fox-Talbot K; Morley M; Pihur V; Chatterjee S; Brandimarto J; Moravec CS; Pulit SL; ; Pfeufer A; Mullikin J; Ross M; Green ED; Bentley D; Newton-Cheh C; Boerwinkle E; Tomaselli GF; Cappola TP; Arking DE; Halushka MK; Chakravarti A
    Am J Hum Genet; 2014 Jun; 94(6):854-69. PubMed ID: 24857694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2.
    Kolder ICRM; Tanck MWT; Postema PG; Barc J; Sinner MF; Zumhagen S; Husemann A; Stallmeyer B; Koopmann TT; Hofman N; Pfeufer A; Lichtner P; Meitinger T; Beckmann BM; Myerburg RJ; Bishopric NH; Roden DM; Kääb S; Wilde AAM; Schott JJ; Schulze-Bahr E; Bezzina CR
    Circ Cardiovasc Genet; 2015 Jun; 8(3):447-456. PubMed ID: 25737393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the old order Amish.
    Post W; Shen H; Damcott C; Arking DE; Kao WH; Sack PA; Ryan KA; Chakravarti A; Mitchell BD; Shuldiner AR
    Hum Hered; 2007; 64(4):214-9. PubMed ID: 17565224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study of electrocardiographic and heart rate variability traits: the Framingham Heart Study.
    Newton-Cheh C; Guo CY; Wang TJ; O'donnell CJ; Levy D; Larson MG
    BMC Med Genet; 2007 Sep; 8 Suppl 1(Suppl 1):S7. PubMed ID: 17903306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome.
    Lahrouchi N; Tadros R; Crotti L; Mizusawa Y; Postema PG; Beekman L; Walsh R; Hasegawa K; Barc J; Ernsting M; Turkowski KL; Mazzanti A; Beckmann BM; Shimamoto K; Diamant UB; Wijeyeratne YD; Kucho Y; Robyns T; Ishikawa T; Arbelo E; Christiansen M; Winbo A; Jabbari R; Lubitz SA; Steinfurt J; Rudic B; Loeys B; Shoemaker MB; Weeke PE; Pfeiffer R; Davies B; Andorin A; Hofman N; Dagradi F; Pedrazzini M; Tester DJ; Bos JM; Sarquella-Brugada G; Campuzano Ó; Platonov PG; Stallmeyer B; Zumhagen S; Nannenberg EA; Veldink JH; van den Berg LH; Al-Chalabi A; Shaw CE; Shaw PJ; Morrison KE; Andersen PM; Müller-Nurasyid M; Cusi D; Barlassina C; Galan P; Lathrop M; Munter M; Werge T; Ribasés M; Aung T; Khor CC; Ozaki M; Lichtner P; Meitinger T; van Tintelen JP; Hoedemaekers Y; Denjoy I; Leenhardt A; Napolitano C; Shimizu W; Schott JJ; Gourraud JB; Makiyama T; Ohno S; Itoh H; Krahn AD; Antzelevitch C; Roden DM; Saenen J; Borggrefe M; Odening KE; Ellinor PT; Tfelt-Hansen J; Skinner JR; van den Berg MP; Olesen MS; Brugada J; Brugada R; Makita N; Breckpot J; Yoshinaga M; Behr ER; Rydberg A; Aiba T; Kääb S; Priori SG; Guicheney P; Tan HL; Newton-Cheh C; Ackerman MJ; Schwartz PJ; Schulze-Bahr E; Probst V; Horie M; Wilde AA; Tanck MWT; Bezzina CR
    Circulation; 2020 Jul; 142(4):324-338. PubMed ID: 32429735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common variant of NOS1AP is associated with QT interval duration in a Chinese population with Type 2 diabetes.
    Lu J; Hu C; Hu W; Zhang R; Wang C; Qin W; Yu W; Xiang K; ; Jia W
    Diabet Med; 2010 Sep; 27(9):1074-9. PubMed ID: 20722683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A NOS1AP gene variant is associated with a paradoxical increase of the QT-interval shortening effect of digoxin.
    Soroush N; Aarnoudse AJ; Kavousi M; Kors JA; Ikram MA; Newton-Cheh C; Ahmadizar F; Stricker BH
    Pharmacogenomics J; 2022 Feb; 22(1):55-61. PubMed ID: 34616002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalization of variants identified by genome-wide association studies for electrocardiographic traits in African Americans.
    Jeff JM; Ritchie MD; Denny JC; Kho AN; Ramirez AH; Crosslin D; Armstrong L; Basford MA; Wolf WA; Pacheco JA; Chisholm RL; Roden DM; Hayes MG; Crawford DC
    Ann Hum Genet; 2013 Jul; 77(4):321-32. PubMed ID: 23534349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac muscle-restricted partial loss of Nos1ap expression has limited but significant impact on electrocardiographic features.
    Smith A; Auer D; Johnson M; Sanchez E; Ross H; Ward C; Chakravarti A; Kapoor A
    G3 (Bethesda); 2023 Nov; 13(11):. PubMed ID: 37708408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study.
    Raitakari OT; Blom-Nyholm J; Koskinen TA; Kähönen M; Viikari JS; Lehtimäki T
    Ann Med; 2009; 41(2):144-51. PubMed ID: 18785031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation.
    van Noord C; Aarnoudse AJ; Eijgelsheim M; Sturkenboom MC; Straus SM; Hofman A; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    Pharmacogenet Genomics; 2009 Apr; 19(4):260-6. PubMed ID: 19247217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia.
    Jamshidi Y; Nolte IM; Dalageorgou C; Zheng D; Johnson T; Bastiaenen R; Ruddy S; Talbott D; Norris KJ; Snieder H; George AL; Marshall V; Shakir S; Kannankeril PJ; Munroe PB; Camm AJ; Jeffery S; Roden DM; Behr ER
    J Am Coll Cardiol; 2012 Aug; 60(9):841-50. PubMed ID: 22682551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.